August 31, 2023 - September 5, 2023

Saroja Pharma Industries IPO Review & Recommendations

Dilip Davda recommend to "Avoid" the IPO.

Saroja Pharma Industries IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	0	0	0	1	0
%	0.00	0.00	0.00	100.00	0.00

Saroja Pharma Industries IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Dilip Davda	Avoid

Saroja Pharma Industries IPO Review by Dilip Davda (Avoid)

[Dilip Davda] SPIIL is currently in the trading of specialty chemicals and pharma APIs. It has posted inconsistency in its financial performance for the reported periods. The company plans to enter manufacturing activities soon. However, the asking price appears to be greedy based on its financial data so far. The small equity post-IPO indicates longer gestation for migration to the mainboard. There is no harm in skipping this “High Risk/Low Return” bet. Read detail review...

Saroja Pharma Industries IPO Peer Comparison

Saroja Pharma Industries India Limited peer comparison with similar listed entities. () (As on March 31, 2023)

Company Name	EPS (Rs)		NAV (per share) (Rs)	P/E (x)	RoNW (%)
Company Name	EPS Basic	EPS Diluted	NAV (per share) (Rs)	P/E (x)	RoNW (%)
Saroja Pharma Industries India Limited	3.61	3.61	17.33	23.27	20.85
NGL Fine Chem Limited	84.57	84.57	334.35	23.15	25.29
Sequent Scientific Limited	0.60	0.60	41.92	223.00	1.42

1 Based on March 31st, 2023 restated financials statements.

2 Source: Annual Report of Peer Group Companies available on Stock Exchange.

3 Basic & diluted Earnings per share (EPS) is calculated in weighted average number of shares after considering Bonus Issue of Shares.

4 Price Earing (P/E) Ratio in relation to offer Price of ₹ 84/- per shares.

Saroja Pharma Industries IPO Review by Members

Saroja Pharma Industries IPO Reviews, analysis and views by popular members. Read Saroja Pharma Industries India Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Saroja Pharma Industries IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	2	1
%	0.00	0.00	66.67	33.33

Member	Review
PHARROAD WALE BABAJI	Neutral E bhai jara dekh ke Paisa Kamana bahoto mushkil hai lekin jaata hai 1 Jhatka mein. September 5, 2023 6:36:25 AM
Mr G	Neutral as the company wants to set up a manufacturing people may apply and can try by investing in one lot August 29, 2023 1:45:36 PM
KHL	Avoid If you want to invest in this company at IPO, better you keep your money with you, you will get at cheaper rate at the time of listing. This is my personal opinion. 1 August 29, 2023 10:48:11 AM

Member

Review

PHARROAD WALE BABAJI

Neutral

E bhai jara dekh ke Paisa Kamana bahoto mushkil hai lekin jaata hai 1 Jhatka mein.

September 5, 2023 6:36:25 AM

Mr G

Neutral

as the company wants to set up a manufacturing people may apply and can try by investing in one lot

August 29, 2023 1:45:36 PM

KHL

Avoid

If you want to invest in this company at IPO, better you keep your money with you, you will get at cheaper rate at the time of listing.

This is my personal opinion.

August 29, 2023 10:48:11 AM

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.